drugset
drugset / Trial / NCT04122599

Melatonin for Prevention of Post Stroke Delirium

NCT04122599 ↗

Phase 2/3 Unknown 2000 enrolled University Hospital Tuebingen
NaSingle-groupOpen-labelPrevention

Summary

Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.

Timeline

Start
2017-07-01
Primary completion
2019-11-01
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg —

Indications

delirium